Associate Director, CORE - Solid Tumors

At Genmab, we are dedicated to building extra[not]ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals’ unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees.

Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being proudly authentic and determined to be our best is essential to fulfilling our purpose. Yes, our work is incredibly serious and impactful, but we have big ambitions, bring a ton of care to pursuing them, and have a lot of fun while doing so.

Does this inspire you and feel like a fit? Then we would love to have you join us!

The Associate Director, Center for Outcomes Research ( CORE ) - Solid Tumors is a Global role, and the individual will support Genmab's solid tumor program.

Work arrangement: This role offers flexibility to work away from the office for 20%–40% of a typical schedule. Employees may use this work schedule in increments of single days or multiple consecutive days, provided it does not exceed 40% within a 60-day period, and is approved by the hiring manager.

Responsibilities

• Implement strategies to demonstrate the unmet need in disease/value of products with a focus on outcomes meaningful to payers, clinical decision-makers, and regulators.
• Generate the evidence necessary, through research, to maximize the commercial value of product(s) by demonstrating product differentiation and economic value.
• Support development team needs including real-world evidence and epidemiology data to support safety.
• Manage multiple projects and product budgets to target as directed as well as interact with vendors in the execution of CORE projects.
• Interact with key customers (e.g., MCOs, Center for Medicare & Medicaid Services (CMS), medical experts, HTA bodies for scientific advice etc.) as needed to deliver value messages for product pricing and reimbursement, and optimal utilization.
• Actively collaborate with cross-functional teams in development, commercial, market access, safety, legal and medical affairs to ensure alignment as required.
• Develop communication/publication strategies for given product and publish and present research outcomes at scientific conferences and forums.
• As a member of the CORE team, contribute to department strategy and objectives as well as represent HE&OR on key initiatives.
• As a member of the CORE team, support pipeline assets as needed

Requirements

• Graduate (PhD or Masters) degree and/or relevant work experience in health economics, outcomes research, epidemiology, health services research, public health, health policy

Minimum requirement

• 5+ years in the pharmaceutical industry or a managed care setting in the direct conduct of health economics, outcomes research, real-world evidence, and epidemiology studies.
• Prior experience with outcomes research methods, including study design and analysis.
• Demonstrated research accomplishments as evidenced by a history of peer-reviewed publications.
• Experience working with HTA process in key markets in a market access environment.

For US based candidates, the proposed salary band for this position is as follows:

$192,880.00---$289,320.00

The actual salary offer will carefully consider a wide range of factors, including your skills, qualifications, experience, and location. Also, certain positions are eligible for additional forms of compensation, such as discretionary bonuses and long-term incentives.

When you join Genmab, you’re joining a culture that supports your physical, financial, social, and emotional wellness. Within the first year, regular full-time U.S. employees are eligible for:

• 401(k) Plan: 100% match on the first 6% of contributions
• Health Benefits: Two medical plan options (including HDHP with HSA), dental, and vision insurance
• Voluntary Plans: Critical illness, accident, and hospital indemnity insurance
• Time Off: Paid vacation, sick leave, holidays, and 12 weeks of discretionary paid parental leave
• Support Resources: Access to child and adult backup care, family support programs, financial wellness tools, and emotional well-being support
• Additional Perks: Commuter benefits, tuition reimbursement, and a Lifestyle Spending Account for wellness and personal expenses

Further details on eligibility for compensation and benefits based on role will be provided during the recruitment process

About Genmab

Genmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO®) antibody medicines.

Established in 1999, Genmab is headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com and follow us on LinkedIn and X .

Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website Job Applicant Privacy Notice (genmab.com) .

Please note that if you are applying for a position in the Netherlands, Genmab’s policy for all permanently budgeted hires in NL is initially to offer a fixed-term employment contract for a year, if the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the fixed-term employment contract.